Some diabetes drugs called GLP-1RAs might help protect knee cartilage from breaking down in early lab studies, and this has been seen with drugs like liraglutide, dulaglutide, and exenatide.

8

Pro

0

Against

Evidence from Studies

Supporting (1)

8

Community contributions welcome

8

Effect of glucagon-like peptide-1 receptor agonists in osteoarthritis: A systematic review of pre-clinical and human studies

Systematic Review

Animal

2025 Mar

The study looks at the same types of diabetes drugs mentioned in the claim and finds they help protect joint cartilage in lab and animal studies, which supports the idea that they could help with osteoarthritis.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Effect of glucagon-like peptide-1 receptor agonists in osteoarthritis: A systematic review of pre-clinical and human studies

Score: 8

DOI: 10.1016/j.ocarto.2025.100567

Similar Assertions

Some diabetes drugs like liraglutide and exenatide might help protect cartilage in arthritic joints by slowing down the breakdown of important joint components.

26

0

90%

Some diabetes drugs like liraglutide and semaglutide might help protect knee cartilage by calming inflammation in lab and animal studies — could this mean they help with arthritis?

1

0

86%

A type of diabetes drug might help protect joint cartilage in arthritis by stopping cells from leaking important building blocks.

12

0

85%

These diabetes drugs might actually heal worn-down joints in arthritis, not just reduce pain, by working directly on the joint tissue in ways that matter for people.

29

53

83%

These diabetes-like drugs might help ease joint pain and slow down damage in arthritis by reducing pain, swelling, and joint breakdown.

12

0

80%